Utah Medical Products Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名113/208位。機構持股佔比非常高,中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Utah Medical Products Inc評分
相關信息
行業排名
113 / 208
全市場排名
270 / 4582
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
0
分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Utah Medical Products Inc亮點
亮點風險
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
公司代碼UTMD
公司Utah Medical Products Inc
CEOCornwell (Kevin L)
網址http://www.utahmed.com
常見問題
Utah Medical Products Inc(UTMD)的當前股價是多少?
Utah Medical Products Inc(UTMD)的當前股價是 56.610。
Utah Medical Products Inc 的股票代碼是什麼?
Utah Medical Products Inc的股票代碼是UTMD。
Utah Medical Products Inc股票的52週最高點是多少?
Utah Medical Products Inc股票的52週最高點是65.560。
Utah Medical Products Inc股票的52週最低點是多少?
Utah Medical Products Inc股票的52週最低點是51.260。
Utah Medical Products Inc的市值是多少?
Utah Medical Products Inc的市值是181.38M。
Utah Medical Products Inc的淨利潤是多少?
Utah Medical Products Inc的淨利潤為13.87M。
現在Utah Medical Products Inc(UTMD)的股票是買入、持有還是賣出?
根據分析師評級,Utah Medical Products Inc(UTMD)的總體評級為--,目標價格為--。
Utah Medical Products Inc(UTMD)股票的每股收益(EPS TTM)是多少
Utah Medical Products Inc(UTMD)股票的每股收益(EPS TTM)是3.543。